Abstract
The oncogenic effects of inorganic arsenic compounds in man are well known. Paris (1820) described occupational skin cancers following exposure to arsenic, and v. Pein (1943), Liebegott (1949), Roth (1956), Hess (1956), Galy et al. (1963), Thiers et al. (1967), and Denk et al. (1969) described tumors of the skin, bronchi, and liver in German and French winegrowers. Carcinomas caused by the arsenic content of the drinking water were observed in Reichenstein, Silesia (Geyer, 1898), Cordoba, Argentinia (Arguello et al., 1939), and on the southwest coast of Taiwan (Yeh et al., 1968)1. Experimental studies on arsenic carcinogenicity revealed contradictory results (Askenazy, 1926; Büngeler, 1958; Knoth, 1966; Osswald and Goerttler, 1971).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alderson, H. E. (1935): cited by Neubauer, O. (1947)
Alexander, A.: Arch. Derm. Syph. (Chicago) 129, 5 (1921)
Aliferis (1924): cited by Ullmann, K. (1930)
Amersbach, J.: Arch. Derm. (Wien) 65, 505 (1952)
Anderson, N. P.: Bowen’s precancerous dermatosis and multiple benign superficial epithelioma. Evidence of arsenic as an etiologic agent. Arch. Denn. Syph. (Chicago) 26, 1052 (1932)
Anderson, N. P. (1937): cited by Neubauer, O. (1947)
Anderson, N. P.: cited by Goecermann, W. H., Wilhelm, L. F. X. (1940)
Anderson, N. P. (1943 a): cited by Neubauer, O. (1947)
Anderson, N. P. (1943 b): cited by Neubauer, O. (1947)
Andrews, N. P. (1932): cited by Neubauer, O. (1947)
Applestein, R. (1941): cited by Neubauer, O. (1947)
Arguello, R. A., Cenget, D. D., Tello, E. E.: Cancer and regional edemic chronic arsenicism. Brit. J. Derm. 51, 548 (1939)
Arhelger, S. W., Kremen, A. J.: Arsenical epitheliomas of medicinal origin. Surgery 30, 977 (1951)
Askanazy, M.: Ober den Einfluß des Arsens auf verpflanztes embryonales Gewebe. Verh. dtsch. Ges. Path. 21, 182 (1926)
Ayres, S.: Chronic ulceration of the soles: multiple benign superficial epitheliomas; arsenical keratoses (palms, soles, trunk). Arch. Derm. Syph. (Chicago) 29, 613 (1934)
Ayres, S. (1935): cited by eubauer, O. (1947)
Ayres, S. (1937): cited by Anderson, N. P. (1937)
Ayres, S. (1943): cited by Neubauer, O. (1947)
Barber, H. W. (1924): cited by Ullmann, K. (1930)
Barber, H. W.: Brit. J. Derm. 45, 475 (1933)
Barber, H. W.: Brit. J. Derm. 58, 85 (1939)
Barney, L. (1944): cited by Neubauer, O. (1947)
Bartak, P., Kejda, J.: Arsenbasaliom der Haut in jugendlichem Alter. Hautarzt 23, 457 (1972)
Bauer, K. H.: Das Krebsproblem, 2nd ed. Berlin-Heidelberg-New York: Springer 1963.
Berlin, C., Tager, A.: Psoriasis complicated by cutaneous and visceral carcinomatosis due to ingestion of arsenic. Acta denn. venereol. (Stockh.) 42, 252 (1962)
Bland-Sutton, J. (1916): Brit. Med. J. 2, 788 (1916)
Bloom, D. (1936): cited by Neubauer, O. (1947)
Brocq (1902): cited by Neubauer, O. (1947)
Braun, W.: Krebs an Haut und inneren Organen, hervorgerufen durch Arsen. Dtsch. med. Wschr. 83, 870 (1958)
Bruusgard (1928): cited by Ullmann, K. (1930)
Büngeler, W.: Der Arsenkrebs. Muench. med. Wschr. 100, 1117 (1958)
Cartaz, A. (1877): cited by Ullmann, K. (1930)
Cole and Driver (1929): cited by Ullmann, K. (1930)
Crocker, H. R., Pennet, G. (1901): cited by Ullmann, K. (1930)
Darier, J. (1902): cited by Ullmann, K. (1930)
Degos, R., Delzant, O., Hewitt, J. (1950): cited by Unna, P. J., Memmersheimer, A., Herzberg, J.J. (1963)
Denk, R., Holzmann, H., Lange, H.-J., Greve, D.: Über Arsenspätschäden bei obduzierten Moselwinzern. Med. Welt 20, 557 (1969)
Doepfiner, R. (1959/60): cited by Unna, P. J., Memmersheimer, A., Herzberg, J. J. (1963)
Doty, C. A. (1931): cited by Neubauer, O. (1947)
Dowling, G. B.: Proc. roy. Soc. Med. 38, Sect. Derm. 127 (1945)
Dubreuilh, W. (1910): cited by Ullmann, K. (1930)
Ebert, M. H., Otsuka, M. (1943): cited by Neubauer, O. (1947)
Ehlers, G.: Klinische und histologische Untersuchungen zur Frage arzneimittelbedingter Arsen-Tumoren. Z. Hautkr. 43, 763 (1968)
Fassrainer, S. (1937): cited by Neubauer, O. (1947)
Fierz, U.: Katamnestische Untersuchungen über die Nebenwirkungen der Therapie von Hautkrankheiten mit anorganischem Arsen. Arch. klin. exp. Derm. 227, 286 (1966).
Finsen (1927): cited by Ullmann, K. (1930)
Finsterer, H.: Med. Klirr. 1, 549 (1922)
Fischer, W. (1932): cited by Neubauer, O. (1947)
Fordyce and McKee (1914): cited by Ullmann, K. (1930)
Franseen, C. C., Taylor, G. W.: Arsenical keratoses and carcinomas. Amer. J. Cancer 22, 287 (1934)
Fuhs (1929): cited by Ullmann, K. (1930)
Galy, P., Touraine, R., Brune, J., Rouchier, P., Gallois, P.: Le cancer poulmonaire d’origin arsenicale des vignerons de Beaujolais. J. Franc. Méd. Chir. thor. 17, 303 (1963)
Gelbjerg-Hansen (1924): cited by Ullmann, K. (1930)
Geyer, L.: Über die chronische Hautveränderung beim Arsenicismus und Betrachtungen über die Massenerkrankungen in Reichenstein in Schlesien. Arch. Derm. Syph. (Berl.) 43, 221 (1898)
Goeckermann, W. H., Wilhelm, L. F. X.: Arsenic as cause of cancer of mucous membrane; report of case. Arch. Derm. Syph. (Chicago) 42, 641 (1940)
Goodman, L. S., Gilman, A.: The pharmacological basis of therapeutics. New York: The Macmillan Co., 1970
Gottron, H. A.: Gegenwartsfragen beim Hautkarzinom. Med. Klirr. 49, 1553 (1954).
Gray, A. M. E. (1912): Brit. J. Derm. 24, 325 (1912)
Gross, P. (1931): cited by Neubauer, O. (1947)
Guggenheim, L.: Multiple Präcancerosen (mit präcancerösem Exanthem) und Carcinome, zum großen Teil von bowenoiden Typus nach langjährigem Arsengebrauch. Arch. Derm. Syph. (Berl.) 168, 26 (1933)
Haagensen, C. D.: Amer. J. Cancer 15, 656 (1931)
Haldin-Davis (1939): cited by Neubauer, O. (1947)
Hall, A. F.: Arch. Derm. 50, 148 (1944)
Hamilton, S. R. (1921): cited by Ullmann, K. (1930)
Harbitz, H. F. (1927): cited by Neubauer, O. (1947)
Hartzell, M. B. (1906): cited by Ullmann, K. (1930)
Hartzell, M. B., Stelwagon, H. W. (1899): cited by Ullmann, K. (1930)
Haxthausen, H.: Hospitalstidende 44, 1 (1923)
Haxthausen, H. (1928): cited by Ullmann, K. (1930)
Hebra, H. (1897): cited by Ullmann, K. (1930)
Herxheimer (1926): cited by Ullmann, K. (1930)
Hess (1956): cited by Bauer, K. H. (1963)
Heuss (1902): cited by Ullmann, K. (1930)
Hofmann, E. (1928): cited by Ullmann, K. (1930)
Hohmann, W. J.: Ned. T. Geneesk. 86, 1408 (1942)
Hövelborn, K.: Karzinomentstehung auf chronischen Dermatosen (Psoriasis, Ulcus cruris und Lichen ruber verrucosus, spätexsudatives Ekzematoid). Demi. Wschr. 101, 858 (1935)
Hueper, W. C.: Morphological aspects of experimental actinic and arsenic carcinomas in skin of rats. Cancer Res. 2, 551 (1942)
Hutchinson, J.: Arsenic cancer. Brit. med. J. 2, 1280 (1887)
Hutchinson, J. (1888, 1894, 1898, 1902, 1903): cited by Ullmann, K. (1930)
Hutchinson, J., Albutt, C. (1888): cited by Ullmann, K. (1930)
Hutchinson, J., Bullock, J. E. (1898): cited by Ullmann, K. (1930)
Hutchinson, J., Tay, W. (1898): cited by Ullmann, K. (1930)
Hyde, J. N. (1899): cited by Ullmann, K. (1930)
Jung, E. G., Trachsel, B.: Molekularbiologische Untersuchungen zur Arsencarcinogenese. Arch. klin. exp. Demi. 237, 819 (1970)
Kleine-Natrop, H. E.: Psoriasiscarcinom. Hautarzt 10, 224 (1959)
Kleine-Natrop, H. E.: Multiple Malignome und Hyperkeratosen bei arsenbehandelter Psoriasis. Derm. Wschr. 145, 390 (1962)
Knoth, W.: Arsenbehandlung. Arch. klin. exp. Derm. 227, 228 (1966)
Konrad (1928): cited by Ullmann, K. (1930)
Lane, W. A. (1894): cited by Ullmann, K. (1930)
Laymon, C. W. (1943): cited by Neubauer, O. (1947)
Levin, O. L.: Arch. Derm. Syph. (Chicago) 13, 569 (1926)
Liebegott, G.: Pathologische Anatomie der chronischen Arsenvergiftungen. Dtsch. med. Wschr. 74, 855 (1949)
Löwenberg, M. (1913): cited by Ullmann, K. (1930)
Madsen, A. (1941): cited by Neubauer, O. (1947)
Mayer, L. (1928): cited by Ullmann, K. (1930)
McCormac, H.: Arsenical keratoses: multiple basal cell carcinomata and arsenical “warts.” Proc. roy. Soc. Med. 26, 1553 (1933)
McNeer, G.: Arsenical keratoses and epitheliomas. Ann. Surg. 99, 348 (1934)
Meyhöfer, W., Knoth, W.: Über die Auswirkungen einer langjährigen antipsoriatrischen Arsentherapie auf mehrere Organe unter besonderer Berücksichtigung andrologischer Befunde. Hautarzt 17, 309 (1966)
Miescher (1963): cited by Fierz, U. (1966)
Milian, G. (1931): cited by Neubauer, O. (1947)
Minkowitz, S.: Multiple carcinomata following ingestion of medicinal arsenic. Ann. Intern. Med. 61, 296 (1964)
Montgomery, H.: Arsenic as an etiologic agent in certain types of epithelioma. Arch. Derm. 32, 218 (1935)
Montgomery, H., Waisman, M.: Epithelioma attributable to arsenic. J. invest. Derm. 4, 365 (1941)
Montgomery, R. M. (1942): cited by Neubauer, O. (1947)
Nander (1923): cited by Ullmann, K. (1930)
Neubauer, O.: Arsenical cancer: A review: Brit. J. Cancer 1, 192 (1947)
Neumann, E., Schwank, R.: Multiple malignant and benign epidermal and dermal tumours following arsenic. Acta. denn. venereol. (Stockh.) 40, 400 (1960)
Nicolas, Gate and Lebeuf (1923): cited by Ullmann, K. (1930)
Novey, H. S., Martel, S. H.: Asthma, arsenic, and cancer. J. Allergy clin. Immunol. 44, 315 (1969)
Oliver (1923): cited by Ullmann, K. (1930)
Oliver and Finnerud (1928): cited by Neubauer, O. (1947)
Osswald, H., Goerttler, K.: Leukosen bei der Maus nach diaplazentarer und postnataler Arsen-Applikation. Verh. dtsch. Ges. Path. 55, 289 (1971)
Paris, J. A.: Pharmacologica. London: Philips, 1820, 3rd ed.
Parkhurst, H. J.: cited by Waugh, J. F., Scull, C. W. (1935)
Peck, S. M. (1942): cited by Neubauer, O. (1947)
v. Pein, H.: Ober die Krebsentstehung bei der chronischen Arsenvergiftung. Dtsch. Arch. klin. Med. 190, 429 (1943)
Piper, H. G.: Besondere Verlaufsformen der superfiziellen Epitheliomatose. Denn. Wschr. 112, 429 (1941)
Pozzi, S. (1874): cited by Ullmann, K. (1930)
Pusey (1919): cited by Neubauer, O. (1947)
Pye-Smith, R. J., Hardwoodnutt, W. (1913): cited by Ullmann, K. (1930)
Ramel (1929): cited by Ullmann, K. (1930)
Rasch, C. (1930): cited by Neubauer, O. (1947)
Rasch and Fons (1920): cited by Neubauer, O. (1947)
Rauschkolb (1938): cited by Neubauer, O. (1947)
Regelson, W., Kim, U., Ospina, J., Holland, J. F.: Haemangioendothelial sarcoma of liver from chronic arsenic intoxication by Fowler’s solution. Cancer (Philad.) 21, 514 (1968)
Robba, G. (1920): cited by Unna, P. J., Memmersheimer, A., Herzberg, J. J. (1963).
Robinson, S. (1935): cited by Neubauer, O. (1947)
Robinson, S.: Arch. Derm. 36, 870 (1937)
Robinson, S. (1941): cited by Rodgers, J. D. (1941)
Robson, A. O., Jelliffe, A. M.: Medicinal arsenic poisoning and lung cancer. Brit med. J. 2, 207 (1963)
Rodgers, J. D. (1941): cited by Neubauer, O. (1947)
Rosen, I.: cited by Montgomery, H. (1935)
Roth, F.: Ober die chronische Arsenvergiftung der Moselwinzer unter besonderer Berücksichtigung des Arsenkrebses. Z. Krebsforsch. 61, 287 (1956)
Rousset, M.: Arsenical keratoses associated with carcinomas of the internal organs. Canad. med. J. 78, 416 (1958)
Russel, B. F., Klaber, R. (1945): cited by Neubauer, O. (1947)
Ryan, M. L.: Arch. Denn. Syph. (Chicago) 40, 104 (1939)
Sanderson, K. V.: Arsenic and skin cancer. Trans. St. John’s Hosp. Denn. Soc. (Lond.) 115 (1963)
Schamberg, J. F. (1906): cited by Ullmann, K (1930)
Schönhof (1923): cited by Ullmann, K. (1930)
Schwartz (1926): cited by Ullmann, K. (1930)
Schwenzner, G., Walther, H.: Multiple Basaliome auf Psoriasis vulgaris nach längerer Arsenbehandlung. Z. Hautkr. 28, 204 (1960)
Semon, H. C. (1922): cited by Ullmann, K. (1930)
Semon, H. C.: Proc. roy. Soc. Med. 38, 128 (1945)
Sommers, S. C., McManus, R. G.: Multiple arsenical cancers of skin and internal organs. Cancers (Philad.) 6, 347 (1953)
Stilians, A. W.: J. cutan. Dis. 37, 269 (1919)
Stilians, A. W.: Psoriasis, arsenical dyskeratoses, multiple epitheliomas. Arch. Derm. Syph. (Chicago) 23, 377 (1931)
Szodoray, L. (1961): cited by Unna, P. J., Memmersheimer, A., Herzberg, J. J. (1963).
Thiers, H., Colomb, D., Moulin, G., v. Colin, L.: Le cancer cutané arsenical des viticulteurs du Beaujolais. Ann. Denn. 94, 133 (1967)
Thiovolet, J., Bondet, P., Perrot, H., Claudy, A.: Epithéliomatose sur arsénicisme chronique thérapeutique. Bull. Soc. franç. Denn. Syph. 76, 892 (1969)
Traub, E. F.: Basal-and prickle cell epitheliomatosis following arsenic medication. Arch. Denn. Syph. (Chicago) 36, 198 (1937)
Traub, E. F.: Multiple epitheliomas. Arch. Denn. Syph. (Chicago) 38, 377 (1939).
Trimble (1914): cited be Ullmann, K. (1930)
Trow, E. J.: cited by Montgomery, H. (1935)
Ullmann, K. (1898, 1917, 1922): cited by Ullmann, K. (1930)
Ullmann, K.: Neueres über das As-Carcinom. VIII Congr. int. Denn. Syph., Copenhagen, 1930
Ullmann, K.: Krebsbildung in der Gewerbemedizin und ihre Beziehung zur experimentellen Geschwulstforschung. In: Handbuch der Haut-und Geschlechtskrankheiten. Jadassohn, J. (ed.) Berlin: Springer, 1933, Vol. XII/3, pp. 551–719
Ullmann and Petschek (1906): cited by Ullmann, K. (1930)
llmann and Rona (1916): cited by Ullmann, K. (1930)
Unna, P. J., Memmersheimer, A., Herzberg, J. J.: Das Carcinom bei psoriasis vulgaris — post hoc oder proper hoc? Arch. klin. exp. Denn. 217, 321 (1963)
Voss, F.: Multiple Arsenkarzinome. Strahlentherapie 66, 156 (1939)
Warburg, O.: On the origin of cancer cells. Science 123, 309 (1956)
Warren, M.: Arch. Path. (Chicago) 30, 977 (1940)
Waugh, J. F., Scull, C. W.: Arch. Denn. Syph. (Chicago) 31, 143 (1935)
Weidenfeld, S. (1912): cited by Ullmann, K. (1930)
White, J. C. (1885, 1899): cited by Ullmann, K. (1930)
Wright, C. S., Friedman, R. J.: Psoriasis and multiple superficial epithelioma. Arch. Denn. Syph. (Chicago) 27, 70 (1933)
Wile, U. J. (1912): cited by Ullmann, K. (1930)
Wilhehn, L. F. X.: cited by Ayres, S. (1934)
Wilhelm, L. F. X., Goeckermann, W. H. (1940, 1943): cited by Neubauer, O. (1947).
Wiliamson, A. W. R.: Arsenical skin cancer and lung cancer. Guys Hosp. Rev. 109, 42, (1960)
Wise, F. (1920): cited by Neubauer, O. (1947)
Yeh, S., How, S. W., Lin, C. S.: Arsenical cancer of skin. Cancer (Philad.) 21, 312 (1968).
Zaun, H.: Iatrogene Arsenschäden unter besonderer Berücksichtigung von Hautkrebsen. Dtsch. Ärzteblatt 22, 1217 (1965)
References
Begemann, H.: Klinische Hämatologie. Stuttgart: Georg Thieme 1970
Best, W. R.: Chloramphenicol-associated blood dyscrasias. J. Amer. med Ass. 201, 99 (1967)
Blair, T. R., Bayrd, E. D., Pease, G. L.: Atypical leukemia. J. Amer. med. Ass. 198, 21 (1966)
Block, M., Jacobson, L. O., Bethard, W. F.: Preleukemic acute human leukemia. J. Amer. med. Ass. 152, 1018 (1953)
Brauer, M. J., Dameshek, W.: Hypoplastic anemia and myeloblastic leukemia following chloramphenicol therapy. Report of three cases. New Engl. J. Med. 277, 1003 (1967).
Castoldi, G., Mitus, W. J. (1968): cited by Goh, K. O. (1971)
Cohen,T., Creger, W. P.: Acute myeloid leukemia following seven years of aplastic anemia induced by chloramphenicol. Amer. J. Med. 43, 762 (1967)
Fraumeni, J. F.: Bone marrow depression induced by chloramphenicol or phenylbutazoe. J. Amer. med. Ass. 201, 828 (1967)
Gadner, H., Gethmann, U., Jessenberger, K., Riehm, H.: Acute Leukämie nach Chloramphenicol-Exposition? Ein kasuistischer Beitrag mit Literaturübersicht. Mschr. Kinderheilk. 121, 590 (1973)
Goh, K. O.: Chloramphenicol, acute leukemia and chromosomal vacuolizations. Sth. me. J. 64, 815 (1971)
Goodman, L. S., Gilman, A.: The pharmacological basis of therapeutics. New York: The Macmillan Co., 1970
Hartwich, G., Schwanitz, G., Becker, J.: Chromosomenaberrationen bei einer Benzolleukämie. Dtsch. med. Wschr. 94, 1229 (1969)
Humphries, K. R.: Acute myelomonocytic leukaemia following chloramphenicol therapy. N. Z. med. J. 68, 248 (1968)
Kähler, H. J.: Kritische Beurteilung der Bluterkrankungen nach Anwendung von Chloramphenicol. Stuttgart: Wissenschaftliche Verlagsgesellschaft 1962
Krivit, W., Good, R. A.: Simultaneous occurrence of mongolism and leukemia. J. Pediat. 65, 303 (1964)
Lebon, J., Messerschmitt, J.: Myélose aplasique d’origine médicamenteuse myéloblastose aigue terminale réflexions pathogéniques. Sang 26, 799 (1955)
Mukherji, P. S.: Acute myeloblastic leukaemia following chloramphenicol treatment. Brit. Med. J. 1, 1286 (1957)
Polak, B. C. P., Wesseling, H., Schut, D., Herxheimer, A., Meyler, L.: Blood dyscrasias attributed to chloramphenicol. Acta Med. Scand. 192, 409 (1972)
Rich, M. L.: Fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy. Ann. Intern. Med. 33, 1459 (1950)
Smadel, J. E.: Chloramphenicol (chloromycetin) in the treatment of infectious disease. Amer. J. Med. 7, 671 (1949)
Suhrland, L. G., Weisberger, A. S.: Hematological toxicity of a chloramphenicol analogue. Amer. J. Med. Sci. 244, 54 (1962)
Weisberger, A. S.: Mechanisms of action of chloramphenicol. J. Amer. Med. Ass. 209, 97 (1969)
Weisberger, A. S., Daniel, T. M.: Suppression of antibody synthesis by chloramphenicol analogs. Proc. Soc. Exp. Biol. (N. Y.) 131, 570 (1969)
Yunis, A. A., Bloomberg, G. R.: Chloramphenicol toxicity: Clinical features and pathogenesis. Progr. Hematol. 4, 138 (1964)
References
Angus, B., Gunz, F. W.: Chronic granulocytic leukemia and cancer. Blood 22, 88 (1963).
Aron, E.: Le traitement médical de la maladie de Dupuytren par un agent cytostatique (méthyl-hydrazine). Presse méd. 76, 1956 (1968)
Baihin, P. L., Tindall, J. P., Roenigk, H. H., Hogan, M. D.: Is methotrexate therapy for psoriasis carcinogenic ? J. A. M. A. 232, 359 (1975)
Chievitz, E., Thiede, T.: Complications and causes of death in polycythaemia vera. Acta med. scand. 172, 513 (1962)
Clayson, D. B.: Carcinogenic hazards due to drugs. In: Drug-Induced Diseases. Meyler, L., Peck, H. M. (eds.) Amsterdam: Peck, H. 1972, Vol. IV, pp. 91–109
Craig, S. R., Rosenberg, E. W.: Methotrexate-induced carcinoma? Arch. Derm. 103, 505 (1971)
Dale, G. A., Smith, R. B.: Transitional cell carcinoma of the bladder associated with cyclophosphamide. J. Urol. 112, 603 (1974)
DeVita, V. T., Arseneau, J. C., Sherins, R. J., Canellos, G. P., Young, R. C.: Intensive chemotherapy for Hodgkin’s disease: Long-term complications. Nat. Cancer Inst. Monogr. 36, 447 (1973)
Evans, S., Waters, L., Hardin, B., Matossian, N., Goltra, E., de Luca, V.: Carcinoma primitif du foie, apparu chez un sujet atteint de leucémie myéloide traitée par uréthane. Rev. Hémat. 6, 148 (1951)
Frick, E., Angstwuren, H., Strauss, G.: Immunosuppressive Therapie der multiplen Sklerose. Muench. med. Wschr. 116, 1987 (1974)
Gärtner, U., Schief, A., Stocker, W. G.: Beitrag zum Problem maligner Zweiterkrankungen nach zytostatischer Therapie. Muench. med. Wschr. 117, 671 (1975).
Gutjahr, P., Spranger, J.: Acute leukemia following anticancer treatment. J. Pediat. 87, 1004 (1975)
Hartwich,G.: Nebenwirkungen zytostatischer und immunosuppressiver Therapie. Fortschr. Med. 91, 357 (1973)
Hartwich, G., Butzler, W.: Zweittumoren bei Hämoblastosen unter zytostatischer Therapie. Med. Klin. 66, 1445 (1971)
Heck, J.: Endoxanbehandlung der primär chronischen Polyarthritis. Med. Welt 22, 1077 (1971)
Heckner, F.: Klinische Demonstrationen. Klin. Wschr. 37, 1051 (1959)
Hueper, W. C., Wiley, F. H., Wolte, H. D.: Experimental production of bladder tumours in dogs by administration of beta-naphthylamine. J. industr. Hyg. 20, 46 (1948).
Hunstein, W., von Rehn, K.: Tumorinduktion durch Zytostatika beim Menschen. Dtsch. med. Wschr. 100, 155 (1975)
IARC Monograph Series on the Evaluation of Carcinogenic Risk in Man. Vol. IX. Lyon: International Agency for Research on Cancer, 1975
Kahlau, G.: Der Lungenkrebs. Ergebn. Path. path. Anat. 37, 258 (1954)
Karchner, R. K., Amare, M., Larsen, W. E., Mallouk, A. G., Caldwell, G. G.: Alkylating agents as leukemogens in multiple myeloma. Cancer (Philad.) 33, 1103 (1974)
Klemm, D., Merker, H., Westerhausen, M.: Akute Neuproliferation bei paraproteinämischen Hämoblastosen unter langdauernder Zytostatikabehandlung. Dtsch. med. Wschr. 93, 2063 (1968)
Kyle, R. A., Pierre, R. V., Bayrd, E. D.: Multiple myeloma and acute myelomonocytic leukemia. Report of four cases possibly related to melphalan. New Engl. J. Med. 283, 1121 (1970)
Labedski, L., Fuchs, H. J., Grips, K. H.: Plasmocytom und finale unreifzellige Leukose. Dtsch. med. Wschr. 101, 108 (1976)
Maltoni, C., Chieco, P.: Adriamicina: Un nuovo potente cancerogeno. Gli Ospedali della Vita 2, 107 (1975)
Michot, E.: Beitrag zum Problem des Plasmocytoms ohne Paraproteine. Dtsch. med. Wschr. 93, 2072 (1968)
Min, K. W., Györkey, F.: Interstitial pulmonary fibrosis, atypical epithelial changes, and bronchiolar cell carcinoma following busulfan therapy. Cancer (Philad.) 22, 1027 (1968)
Nelson, B.M., Andrews, G. A.: Breast cancer and cytologic dysplasia in many organs after busulfan (Myleran). Amer. J. clin. Path. 42, 37 (1964)
O’Gara, R. W., Adamson, R. H., Kell, M. G., Dalgard, D. W.: Neoplasms on the hematopoietic system in nonhuman primates. Report of tumors and two leukemias induced by procarbazine. J. nat. Cancer Inst. 46, 1121 (1971)
Philips, F. S., Gilladoga, A., Marquardt, H., Sternberg, S. S., Vidal, P. M.: Some observations on the toxicity of adriamycin. Cancer Chemother. Rep. 6, 177 (1975).
Rehn, L.: Blasengeschwülste bei Fuchsin-Arbeitern. Arch. klin. Chir. 50, 588 (1895).
Reis, H. E., Hossfeld, D. K., Stier, H. W.: Über die Kombination von malignem Tumor und Hämoblastose. Neoplastische Transformation nach Therapie oder Zweiterkrankung. Med. Welt 2, 2411 (1969)
Rieche, K.: Zur Frage der Kanzerogenität von Zytostatika. Arch. Geschwulstforsch. 34, 240 (1969)
Rupprecht, L., Blessing, M. H.: Fibrosarkom der Harnblase nach siebenjähriger Chemotherapie einer Lymphogranulomatose im Kindesalter. Dtsch. med. Wschr. 98, 1663 (1973)
Scherf, H. R., Schmähl, D.: Experimental investigations on immunosuppressive properties of carcinogenic substances in male Sprague-Dawley-rats. Recent Results Cancer Res. 52, 76 (1975)
Schmähl, D.: Karzinogene Wirkung von Cyclophosphamid und Triazichon bei Ratten. Dtsch. med. Wschr. 92, 1150 (1967)
Schmähl, D.: Entstehung, Wachstum und Chemotherapie maligner Tumoren. Aulendorf: Editio Cantor 1970, 2nd ed.
Schmähl, D.: Karzinogenese und Immunodepression. Dtsch. med. Wschr. 45, 1771 (1971)
Schmähl, D.: Investigations on the influence of immunodepressive means on the chemical carcinogenesis in rats. Z. Krebsforsch. 81, 211 (1974)
Schmähl, D.: Experimental investigations with anticancer drugs for carcinogenicity with special reference to immunodepression. Recent Results Cancer Res. 52, 18 (1975)
Schmähl, D., Osswald, H.: Experimentelle Untersuchungen über carcinogene Wirkungen von Krebs-Chemotherapeutika und Immunosuppressiva. Arzneimittel-Forsch. 20, 1461 (1970)
Schmähl, D., Mundt, D., Schmidt, K. G.: Experimental investigations on the influence upon the chemical carcinogenesis. 1 st communication: Studies with ethylnitrosourea. Z. Krebsforsch. 82, 91 (1974)
Schmähl, D., Habs, M.: Absence of carcinogenic effects of estradiol mustard (NSC112259) in rats. Z. Krebsforsch. 87, 197 (1976)
Schmalz, F., Keiser, G., Kresbach, E., Asamer, H., Braunsteiner, H.: Plasmozytom, Alkylantien und akute myelogene Leukämien. Dtsch. med. Wschr. 100, 1961 (1975).
Scott, W. W., Boyd, H. L.: A study of the carcinogenic effect of betanaphthylamine on the normal and substituted sigmoid loop ladder of dogs. J. Urol. 70, 914 (1953).
Shimkin, M. B., Weisburger, J. H., Weisburger, E. K., Gubareff, N., Suntzeff, V.: Bioassay of 29 alkylating chemicals by the pulmonary-tumor response in strain A mice. J. Nat. Cancer Inst. 36, 915 (1966)
Sieber, S. M., Adamson, R. H.: Toxicity of antineoplastic agents in man. Chromosomal aberrations, antifertility effects, congenital malformations, and carcinogenic potential. Advanc. Cancer Res. 22, 57–144 (1975)
Sotrel, G., Jafari, K., Lash, A. F., Stepto, F., Stepto, R. C.: Acute Leukemia in advanced ovarian carcinoma after treatment with alkylating agents. Obstet. Gynec. 47, 67 (1976).
Stavem, P., Harboe, M.: Acute erythroleukaemia in a patient with malphalan for the cold agglutinin syndrome. Scand. J. Haemat. 8, 375 (1971)
Storti, E., Mauri, C., Artusi, T., Traldi, A., Vaccari, G. L.: Zusammentreffen von Leukämie und neoplastischen Lymphopatien. Muench. med. Wschr. 109, 1597 (1967).
Terbrüggen, A.: Neoplastische Retikulose nach zytostatischer Dauerbehandlung von radikal operierten Karzinomen. Verh. Dtsch. Ges. Path. 49, 241 (1965)
Thiede, T., Chievitz, E., Christensen, B. Chr.: Chlornaphazine as a bladder carcinogen. Acta med. Scand. 175, 721 (1964)
Thiede, T., Christensen, B. Chr.: Bladder tumours induced by chlornaphazine. Acta med. scand. 185, 133 (1969)
Videbaek, A.: Chlornaphazin (ErysanR) may induce cancer of the urinary bladder. Acta med. scand. 176, 45 (1964)
Vormittag, W.: Zytostatische Therapie, chromosomale Aberrationen und karzinogene Wirkung. Wien. klin. Wschr. 86, 69 (1974)
Wada, S., Miyanishi, M., Nishimoto, Y., Kambe, S.: Mustard gas as a cause of cancer in man. Lancet, I, 68, 1161 (1968)
Wall, R. L., Clausen, K. P.: Carcinoma of the bladder in patients receiving cyclophosphamide. New Engl. J. Med. 293, 271 (1975)
Weisburger, J. H., Griswold, D. P., Prejeau, J. D., Casey, A. E., Wood, H. B., Weisburger, E. K.: The carcinogenic properties of some of the principal drugs used in clinical cancer chemotherapy. Recent Results Cancer Res. 52, 1 (1975)
Weiss, A., Weiss, B.: Karzinogenese durch Lost-Exposition beim Menschen, ein Wildhack, R.: Monozytenleukämie mit G-Paraproteinämie nach Röntgenbestrahlung und zytostatischer Behandlung eines Myosarkoms. Dtsch. med. Wschr. 92, 255 (1967).
Worth, P. H. L.: Cyclophosphamide and the bladder. Brit. med. J. 3, 182 (1971)
References
Allison, A. C.: Tumor development following immunosuppression. Proc. Roy. Soc. Med. 63, 1077 (1970)
Andrews, E. J.: Failure of immunosurveillance against chemically induced in situ tumors in mice. J. Nat. Cancer Inst. 52, 729 (1974)
Enderlin, F., Guysan, Y.: Maligne Tumoren unter Immunosuppressiva, ein neues Problem beim Transplantationsempfänger. Heiv. Chir. Acta 40, 773 (1973)
Gatti, R. A., Good, R. A.: Occurrence of malignancy in immunodeficiency diseases. Cancer (Philad.) 28, 89–97 (1971)
Gleichmann, A., Gleichmann, E.: Immunosuppression and neoplasia. Klin. Wschr. 51, 255 (1973)
Haerer, A. F., Jackson, J. F., Evers, C. G.: Ataxia teleangiectasia with gastric adenocarcinoma. J. Amer. Med. Ass. 210, 1884 (1969)
Hamoudi, A. B., Ertel, J., Newton, W. A., Reiner, C. B., Clatworthy, H. W.: Multiple neoplasm in a child associated with IGA deficiency. Cancer (Philad.) 33, 1134 (1974).
Kroes, R., Weiss, J. W., Weisburger, J H.: Immune suppression and chemical carcinogenesis. Recent Results Cancer Res. 52, 65 (1975)
Levin, S., Perlov, S.: Ataxia-Teleangiectasia. Israel J. Med. Sci. 7, 1535 (1971)
Martin, D. C., Rubin, M., Rosen, V. J.: Cadaveric renal homotransplantation with inadvertent transplantation of carcinoma. J. Amer. Med. Ass. 192, 82 (1965).
McKhann, C. F.: Primary malignancy in patients undergoing immunosuppression for renal transplantation. Transplantation 8, 209 (1969)
Page, A. R., Hansen, A. E., Good, R. A.: Occurrence of leukemia and lymphoma in patients with agammaglobulinemia. Blood 21, 197 (1963)
Penn, I.: Malignant tumors in organ transplant recipients. Recent Results Cancer Res. 35, 1 (1970)
Penn, I.: Malignant diesease in immunodeficient states in man. Recent Results Cancer Res. 52, 96 (1975)
Penn, I., Starzl, T. E.: Malignant lymphomas in transplantation patients. Int. J. Clin. Pharmacol. 3, 49 (1970)
Scherf, H. R., Krüger, C., Karsten, C.: Untersuchungen an Ratten über immunosuppressive Eigenschaften von Cytostatica unter besonderer Berücksichtigung der carcinogenen Wirkung. Arzneimittel-Forsch. 20, 1467 (1970)
Scherf, H. R., Schmähl, D.: Experimental investigations on immunodepressive properties of carcinogenic substances in male Sprague-Dawley-rats. Recent Results Cancer Res. 52, 76 (1975)
Schmähl, D.: Wert und Gefahr der Krebschemotherapie. Dtsch. med. Wschr. 88, 1463 (1963)
Schmähl, D.: Entstehung, Wachstum und Chemotherapie maligner Geschwülste. Aulendorf: Editio Cantor, 1970, 2nd ed.
Schmähl, D.: Karzinogenese und Immunodepression. Dtsch. med. Wschr. 45, 1771 (1971)
Schmähl, D.: Investigations on the influence of immunodepressive means on the chemical carcinogenesis in rats. Z. Krebsforsch. 81, 211 (1974)
Schmähl, D.: Experimental investigations with anticancer drugs for carcinogenicity with special reference to immunodepression. Recent Results Cancer Res. 52, 18 (1975).
Schmähl, D., Danisman, A., Habs, M., Diehl, B.: Experimental investigations upon the chemical carcinogenesis. 3rd communication: Studies with 1,2-dimethylhydrazine. Z. Krebsforsch. 86, 89–94 (1976)
Schmähl, D., Habs, M., Diehl, B.: Experimental investigations on the influence upon the chemical carcinogenesis. 2nd. communication: Studies with 3,4-benzopyrene. Z. Krebsforsch. 86, 85— 88 (1976)
Schmähl, D., Mundt, D., Schmidt, K. G.: Experimental investigations on the influence upon chemical carcinogenesis. 1st communication: Studies with ethylnitrosourea. Z. Krebsforsch. 82, 91 (1974)
Schmähl, D., Sattler, W.: Der Einfluß der Vorbehandlung von Ratten mit alkylierenden Substanzen und anderen Giften auf das Wachstum des Yoshida-Sarkoms. Arzneimittel-Forsch. 14, 746 (1964)
Schmähl, D., Stutz, E.: Abhängigkeit der Tumorentwicklung bei Ratten nach i. v. Injektion des Yoshida-Aszites-Sarkoms von vorausgegangener Röntgenganzkörperbestrahlung. Naturwissenschaften 49, 424 (1962)
Waldmann, T. A.: Immunodeficiency disease and neoplasia. Ann. Intern. Med. 77, 605 (1972)
References
Crowley, J. D., Still, W. J. S.: Metastatic carcinoma at the site of injection of iron-dextran complex. Brit. Med. J. 1, 1411 (1960)
Golberg, L.: cited by Thedering, F. (1964)
Haddow, A., Horning, E. S.: cited by Thedering, F. (1964)
MacKinnon, A. E., Bancewicz, J.: Sarcoma after injection of intramuscular iron. Brit. Med. J. 2, 277 (1973)
Richmond, H. G.: Induction of sarcoma in the rat by iron-dextran complex. Brit. med. J. 2, 277 (1973)
Robinson, C. E. G., Bell, D. N., Sturdy, J. H.: Possible association of malignant neoplasm with iron-dextran injection. Brit. med. J. 2, 648 (1960)
Thedering, F.: Die Verträglichkeit der Eisentherapie unter Berücksichtigung der karzinogenen Wirkung des Dextraneisenkomplexes. Med. Welt 15, 277 (1964).
Willis, R. S.: The spread of tumours in the human body. London: Butterworth, 1952
Worthy, T. S., Wynne, E. J. C.: Metastastic carcinoma at the site of injection of penicillin. Brit. Med. J. 2, 1208 (1960)
References
Alberto, P., Cougn, R., Maurice, P., Weber, J.: Trois cas de lymphome malin ou pseudolymphome chez des épileptiques traités par la diphénylhydantoine. Schweiz. med. Wschr. 101, 1773 (1970)
Beil, E., Prechtel, K.: Malignes Lymphom oder Hydantoin-Lymphadenopathie. Muench. med. Wschr. 115, 2033 (1973)
Charlton, M. H., Lunsford, E.: Cited in Leading Articles. Lancet, 1971
Clemmesen, J., Fuglsang-Frederiksen, V., v. Pleim, C. M.: Are anticonvulsants carcinogenic? Lancet 1974, 705–707
Gams, R. A., Neal, J. A., Conrad, F. G.: Hydantoin-induced pseudolymphoma. Ann. Intern. Med. 69, 557 (1968)
Gebert, P., Lorenz, K.: Maligne Hämoblastosen nach prophylaktischen und therapeutischen Maßnahmen. Dtsch. Gesundh.-Wes. 23, 1318 (1968)
Hyman, G. A., Sommers, S. C.: The development of Hodgkin’s disease and lymphoma during anticonvulsant therapy. Blood 28, 416 (1966)
Juhasz, J., Balo, J., Szende, B.: Tumors induced by diphenylhydantoin. Acta Morph. Acad. Sci. Hung. 18, 147 (1970)
Krüger, G.: Zur Pathogenese von Tumoren des lymphoretikulären Gewebes bei Transplantationsempfängern. Verh. Dtsch. Ges. Path. 54, 175 (1970)
Krüger, G., Harris, D., Sussman, E.: Effect of dilantin in mice. II. Lymphoreticular tissue atypia and neoplasia after chronic exposure. Z. Krebsforsch. 78, 290 (1972)
Leading Articles: Is phenytoin carcinogenic? Lancet (1971) 1071
Leder, L. D., Lennert, K.: Über iatrogene Lymphknotenveränderungen. Verh. Dtsch. Ges. Path. 54, 310 (1972)
McCarthy, D. D., Chalmers, T. M.: Haematological complications of phenylbutazone therapy. Review of the literature and report of two cases. Canad. Med. Ass. J. 90, 1061 (1964)
Rausing, A., Trell, E.: Malignant lymphogranulomatosis and anticonvulsant therapy. Acta Med. Scand. 189, 131 (1971)
Saltzstein, S. L., Ackermann, L. V.: Lymphadenopathia induced by anticonvulsant drugs mimicking clinically and pathologically malignant lymphomas. Cancer (Philad.) 12, 164 (1959)
Stich, W., Ehrhart, H. (1963): cited by Wildhack, R. (1973)
Wildhack, R.: Leukämie und Hydantoin-Behandlung. Muench. med. Wschr. 115, 1275 (1973)
References
Adam, W. R., Dawborn, J. K., Price, C. G., Riddel, J., Story, H.: Anaplastic transitional-cell carcinoma of the renal pelvis in association with analgesic abuse. Med. J. Aust. 57, 1108 (1970)
Angervall, L., Bengtsson, U., Zetterlund, G., Zsigmond, M.: Renal pelvic carcinoma in a Swedish district with abuse of a phenacetin-containing drug. Brit. J. Urol. 41, 401 (1969)
Begley, M., Chadwick, J. M., Jepson, R. P.: A possible case of analgesic abuse associated with transitional-cell carcinoma of the bladder. Med. J. Aust. 57, 1133 (1970).
Bengtsson, U., Angervall, L.: Analgesic abuse and tumours of the renal pelvis. Lancet 1, 305 (1970)
Bengtsson, U., Angervall, L., Ekmann, H., Lehmann, L.: Transitional-cell tumours of the renal pelvis in analgesic abusers. Scand. J. Urol. Nephrol. 2, 145 (1968)
Bock, K. D., Hogrefe, J.: Analgeticaabusus und maligne Tumoren der ableitenden Harnwege. Muench. med. Wschr. 114, 645 (1972)
Blich, H., Häuser, H., Pfleger, K., Rüdiger, W.: Über die Ausscheidung eines noch nicht beschriebenen Phenacetinmetaboliten beim Menschen und bei der Ratte. NaunynSchmiedebergs Arch. Exp. Path. Pharmak. 253, 25 (1966)
Deming, C. L.: Tumors of the kidney. In: Urology. Campbell, M. F. (ed.) London — Philadelphia: W. B. Saunders Co. 1963
Dubach, U. C., Raaflaub, J. (1969): cited by Leistenschneider, W., Ehmann, R. (1973).
Fripp, D. J.: The origin of urinary-beta glucuronidase. Brit. J. Cancer 19, 330 (1965)
Goodman, L. S., Gilman, A.: The pharmacological basis of therapeutics. New York: The Macmillan Co. 1970
Grace, D. A.: Carcinoma of the renal pelvis: A 15 year review. J. Urol. 98, 566 (1967)
Grob, H. U.: Phenacetinabusus und Nierenbeckencarcinom. Helv. Chir. Acta 38, 537 (1971)
Hobye, G.,ielsen, O. E.: Renal pelvic carcinoma in phenacetin abusers. Scand. J. Urol. Nephrol. 5, 190 (1971)
Hultengren, N.: Renal papillary necrosis, a clinical study of 103 cases. Acta Chir. Scand. Suppl. 277 (1961)
Hultengren, N., Lagergren, C., Ljungvist, A.: Carcinoma of the renal pelvis in renal papillary necrosis. Acta Chir. Scand. 130, 314 (1965)
Landmann, K. G., Rutishauser, G., Dubach, U. C.: Phenacetin-Abusus und Hamwegstumoren. Urologe A 14, 75 (1975)
Landmann-Suter, R., Dubach, U. C.: Phenacetin und Nierenschädigung. Dtsch. med. Wschr. 100, 1451 (1975)
Leistenschneider, W., Ehmann, R.: Nierenbeckencarcinom nach Phenacetinabusus. Schweiz. med. Wschr. 103, 433 (1973)
Mannion, R. A., Susmano, D.: Phenacetin abuse causing bladder tumour. J. Urol. 106, 602 (1971)
Newman, D. M.: Transitional cell carcinoma of the upper urinary tract. J. Urol. 98, 322 (1967)
Riches, E.: Tumors of the kidney and ureter. In: Handbuch der Urologie. Alken, C. E., Dix, V. W., Weyrauch, H. M., Wildholz, E. (eds.): Berlin — Heidelberg — New York: Springer 1967, Vol. XI/1,1
Schmähl, D.: Toxikologische Probleme der iatrogenen Carcinogenese. Verh. Dtsch. Ges. Path. 56, 133 (1972)
Schmähl, D., Reiter, A.: Fehlen einer cancerogenen Wirkung beim Phenacetin. Arzneimittel-Forsch. 4, 404 (1954)
Spühler, O., Zollinger, H. U.: Die chronische interstitielle Nephritis. Z. klin. Med. 151, 1 (1953)
References
Abatt, J. D., Lea, A. J.: Leukaemogens. Lancet 2, 880 (1958)
Bean, R. H. D.: Phenylbutazone and leukaemia: A possible association. Brit. Med. J. 2, 1552 (1960)
Begemann, H.: Klinische Hämatologie. Stuttgart: Georg Thieme, 1970
Cadman, E. F. B., Limont, W.: Phenylbutazone and leukaemia. Brit. Med. J. 1, 798 (1962)
Cast, I. P.: Phenylbutazone and leukaemia. Brit. Med. J. 2, 1569 (1961)
Chalmers, T. M., McCarthy, D. D.: Phenylbutazone therapy associated with leukaemia. Brit. Med. J. 1, 747 (1964)
Chatterjea, J. B.: Leukemia and Phenylbutazone. Brit. Med. J. 2, 875 (1964)
Dougan, L., Woodliff, H. J.: Acute leukaemia associated with phenylbutazone treatment: A review of the literature and report of a further case. Med. J. Aust. 1, 217 (1965)
Fraumeni, J. F.: Bone marrow depression induced by chloramphenicol or phenylbutazone. J. Amer. med. Ass. 201, 828 (1967)
Garrett, J. V.: Phenylbutazone and leukaemia. Brit. med. J. 1, 53 (1961)
Golding, J. R., Hamilton, M. G., Moody, H. E.: Monocytic leukemia and phenylbutazone. Brit. med. J. 1, 1673 (1965)
Goodman, L. S., Gilman, A.: The pharmacological basis of therapeutics. New York: The Macmillan Co. 1970
Hart, G. D.: Leukaemia and phenylbutazone. Brit. med. J. 2, 569 (1964)
Jensen, M. D., Roll, K.: Phenylbutazone and leukaemia. Acta med. scand. 176, 505 (1965)
Leavesley, G. M., Stenhouse, N. S., Dougan, L., Woodliff, H. J.: Phenylbutazone and leukaemia. Is there a relationship? Med. J. Aust. 56, 963 (1969)
Lorenz, K., Gebert, P.: Maligne Retikulose nach Phenylbutazon-Therapie. Kausalbeziehung oder zufälliges Zusammentreffen? Muench. med. Wschr. 110, 2283 (1968).
Peters, D., Sjöberg, S. G. (1965): cited by Fraumeni, J. F. (1967)
Scheuer-Karpin, R. (1965): cited by Lorenz, K., Gebert, P. (1968)
Sen, S., Siddique, K. K. H.: Phenylbutazone and leukaemia. Bull. Inst. postgrad. med. Educ. Res. 6, 23 (1964)
Stewart (1964): cited by Fraumeni, J. F. (1967)
Thorpe, G. J.: Leukaemia and phenylbutazone. Brit. med. J. 1, 1707 (1964)
Woodliff, H. J., Dougan, L.: Acute leukaemia associated with phenylbutazone treatment. Brit. med. J. 1, 744 (1964)
References
Arzneimittelkommission der Deutschen Ärzteschaft: Anwendung von Diäthylstilböstrol in der Schwangerschaft. Dtsch. Ärzteblatt 69, 539 (1972)
Fetherston, W. C., Meyers, A., Speckhard, M. E.: Adenocarcinoma of the vagina in young women. The stilbestrol-adenosis-adenocarcinoma of the vagina syndrome. Wis. Med. J. 71, 87 (1972)
Folkmann, J.: Transplacental carcinogenesis by stilbestrol. New Engl. J. Med. 285, 404 (1971)
Forsberg, J. G. (1969): cited by Forsberg, J. G. (1972)
Forsberg, J. G.: Estrogen, vaginal cancer, and vaginal development. Amer. J. Obstet. Gynec. 113, 83 (1972)
Greenwald, P., Barlow, J. J., Nasca, P. C., Burnett, W. S.: Vaginal cancer after maternal treatment with synthetic estrogens. New Engl. J. Med. 285, 390 (1971)
Herbst, A. L., Kurman, R. J., Scully, R. E.: Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Obstet. Gynec. 40, 287 (1972)
Herbst, A. L., Scully, R. E.: Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer (Philad.) 25, 745 (1970)
Herbst, A. L., Ulfelder, H., Poskanzer, D. C.: Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. New Engl. J. Med. 284 878 (1971 a)
Herbst, A. L., Ulfelder, H., Poskanzer, D. C.: Registry of clear-cell carcinoma of genital tract in young women. New Engl. J. Med. 285 407 (1971 b)
Hill, E. C.: Clear cell carcinoma of the cervix and vagina in young women. Amer. J. Obstet. Gynec. 116, 470 (1973)
Ivankovic, S.: Praenatale Carcinogenese. In: Handbuch der allgemeinen Pathologie. Geschwülste, Tumors III, Altmann, H.-W., Büchner, F., Cottier, H., Grundmann, E., Holle, G., Letterer, E., Masshoff, W., Meesen, H., Roulet, F., Seifert, G., Siebert, G. (eds.) Berlin-Heidelberg-New York: Springer 1975 Vol. 6, part 7, pp. 941–1002
Kantor, H. I., Weinstein, S. A., Kaye, H. L.: Clear cell adenocarcinoma in young women. Obstet. Gynec. 41, 443 (1973)
Kern, G.: Gynäkologie. Stuttgart: Georg Thieme 1973
Langmuir, A. D.: New environmental factor in congenital disease. New Engl. J. Med. 284, 912 (1971)
Lewis, J. L., Nordquist, S. R. B., Richart, R. M.: Studies of nuclear DNA in vaginal adenosis and clear cell adenocarcinoma. Amer. J. Obstet. Gynec. 115, 737 (1973).
Noller, K. L., Decker, D. G., Lanier, A. P., Kurland, L. T.: Clear-cell adenocarcinoma of the cervix after maternal treatment with synthetic estrogens. Mayo Clin. Proc. 47, 629 (1972)
Ulfelder, H.: The stilbestrol-adenosis-carcinoma syndrome. Cancer (Philad.) 38, 426 (1976)
Ulfelder, H., Poskanzer, D., Herbst, A. L.: Stilbestrol-adenosis-carcinoma syndrome geographic distribution. New Engl. J. Med. 285, 691 (1971)
Vooijs, P. G., Ng, A. B. P., Wentz, W. B.: The detection of vaginal adenosis and clear cell carcinoma. Acta Cytol. (Baltimore) 17, 59 (1973)
References
Alexander, I. O., Macrosson, K. I.: Squamous epithelioma probably due to tar ointment in a case with psoriasis. Brit. Med. J. 2, 1089 (1954)
Batter. K. H.: Das Krebsproblem. Berlin-Heidelberg-Göttingen: Springer 1963
Berghoff, W.: Über Organveränderungen bei Mäusen nach Teerpinselung. Z. Krebsforsch. 26, 468 (1928)
Berenblum, I.: Liquor picis carbonis (B. P.). A carcinogenic agent. Brit. med. J. 2, 601 (1948)
Carli, G. (1958): cited by Greither, A., Gisbertz, C., Ippen, H. (1967)
De Jong, S. I., Meyer, J., Martineau, J. (1935): cited by Greither, A., Gisbertz, C., Ippen, H. (1967)
Gottron, H. A.: Gegenwartsfragen beim Hautkarzinom. Med. Klin. 49, 1553 (1954).
Gottron, H. A.: Karzinogene Wirkung teerhaltiger Salben? Med. Klin. 60, 1679 (1965).
Greither, A., Gisbertz, C., Ippen, H.: Teerbehandlung und Krebs. Z: Hautkr. 42, 631 (1967)
Henry, S. A., (1948): cited by Greither, A., Gisbertz, C., Ippen, H. (1967)
Hirohata, T., Masuda, Y., Horie, A., Kuratsune, M.: Carcinogenicity of tar-containing skin drugs: animal experiment and chemical analysis. Gann 64, 323 (1973)
Hodgson, G.: Epithelioma following the local treatment of pruritus ani with liquor picis carbonis. Brit. J. Derm. 60, 282 (1948)
Kennaway, E.: Brit. Med. J. 1, 564 (1924)
Kovtounovitch, G. P.: cited by Greither, A., Gisbertz, C., Ippen, H. (1967)
Lipschutz, B.: Z. Krebsforsch. 21, 50 (1924)
Moeller, K. O.: Pharmakologie. Basel-Stuttgart: Schwabe & Co. 1961
Müller, S., Kierland, R.: Crude coal tar in dermatologic therapy. Proc. Mayo Clin. 39, 275 (1964)
Opfer, K.: Karzinom auf Psoriasis durch Arsen-oder Teerbehandlung. Dermatologica 8086(1939)
Pott, P.: Chirurgical observations relative to the cataract, the polypos of the nose, the cancer of the scrotum, the different kinds of ruptures and the mortification of the toes and feet. London: 1775
Rook, A. J., Gresham, G. A., Davis, R. A.: Squamous epithelioma possibly induced by the therapeutic application of tar. Brit. J. Cancer 10, 17 (1956)
Sonneck, H. J., Koch, H.: Skrotalkarzinom nach langjähriger unkontrollierter Teerbehandlung eines Ekzems. Derm. Wschr. 148, 40 (1963)
Sternberg, A.: Z. Kerbsforsch. 20, 420 (1923)
Veiel, F.: Teerkrebs beim Menschen. Arch. Derm. Syph. (Berl.) 148, 142 (1924)
Volkmann, S. (1875): cited by Bauer, K. H. (1963)
Yamagiwa, K., Ishikawa, K. (1918): cited by Bauer, K. H. (1963)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Schmähl, D., Thomas, C., Auer, R. (1977). Examples of Iatrogenic Carcinogenesis in the Field of Internal Medicine and its Marginal Areas. In: Iatrogenic Carcinogenesis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66630-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-66630-8_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-08200-2
Online ISBN: 978-3-642-66630-8
eBook Packages: Springer Book Archive